Key result
Microalbuminuria independently predicted all-cause mortality (HR 1.48; 95% CI 1.20-1.79) and cardiovascular mortality (HR 2.03; 95% CI 1.55-2.67) in the general population.
Why the study?
Does microalbuminuria predict all-cause and cardiovascular mortality in the general population?
Population
20,911 individuals aged 40-79 years from the general population (EPIC-Norfolk Study, UK)
Comparison
Microalbuminuria and macroalbuminuria vs Normoalbuminuria
Design
Cohort
Follow-up
average of 6.3 years
Authors
Loading...
Microalbuminuria was associated with higher mortality in the general population; extends diabetes/hypertension findings but leaves clinical adoption open.
Cohort (n=20,911)
Does microalbuminuria predict all-cause and cardiovascular mortality in the general population?
Effect estimate: HR 1.48 (95% CI 1.20, 1.79)
p-value: p=< 0.001
Microalbuminuria independently predicts all-cause and cardiovascular mortality in the general population, highlighting its potential as a risk stratification tool alongside conventional CVD risk factors.
Matthew F. Yuyun (2004) conducted a cohort in General population (n=20,911). Microalbuminuria vs. Normoalbuminuria was evaluated on All-cause mortality (HR 1.48, 95% CI 1.20, 1.79, p=< 0.001). Microalbuminuria independently predicted all-cause mortality (HR 1.48; 95% CI 1.20-1.79) and cardiovascular mortality (HR 2.03; 95% CI 1.55-2.67) in the general population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: